Domů › Rakovina (všechny typy) › New Mexico › Albuquerque
Klinické studie Rakovina (všechny typy) v Albuquerque, NM
14 studií pro Rakovina (všechny typy) hledá účastníky v lokalitách v Albuquerque a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Probíhá náborFáze 3
- University of New Mexico Cancer Center, Albuquerque
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Probíhá náborFáze 2
- Lovelace Medical Center - Saint Joseph Square, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
- The University of New Mexico Comprehensive Cancer Center, Albuquerque
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Probíhá náborFáze 2
- University of New Mexico, School of Medicine, Albuquerque
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Probíhá náborFáze 1/2
- Research Site, Albuquerque
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Probíhá náborFáze 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Project: Every Child for Younger Patients With Cancer
Probíhá náborObservační studie
- Presbyterian Hospital, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Probíhá náborFáze 3
- University of New Mexico Cancer Center, Albuquerque
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Probíhá náborFáze 2
- 292, Albuquerque
Molecular Genetics Studies of Cancer Patients and Their Relatives
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Lovelace Medical Center-Downtown, Albuquerque
- New Mexico Oncology Hematology Consultants, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
Probíhá nábor
- University of New Mexico Comprehensive Cancer Center, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Albuquerque
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- New Mexico Oncology Hematology Consultants, Albuquerque
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Probíhá náborObservační studie
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Probíhá nábor
- Lovelace Medical Centre-Saint Joseph Square, Albuquerque
- Lovelace Women's Hospital, Albuquerque
Studie Rakovina (všechny typy) v jiných městech
- Houston, TX121 studií
- New York City, NY110 studií
- Boston, MA86 studií
- Los Angeles, CA73 studií
- Nashville, TN65 studií
- Philadelphia, PA59 studií
- Durham, NC58 studií
- Washington, DC58 studií
- Chicago, IL51 studií
- Seattle, WA49 studií
- Atlanta, GA49 studií
- Arlington, VA48 studií
Další studie v Albuquerque
- Nemalobuněčný plicní karcinom18 studií
- Rakovina prsu17 studií
- Rakovina vaječníků15 studií
- Rakovina plic14 studií
- Rakovina endometria12 studií
- Metastatický karcinom12 studií
- Diabetes mellitus 2. typu11 studií
- Kardiovaskulární onemocnění10 studií
- Rakovina prostaty9 studií
- Melanom9 studií
- Akutní myeloidní leukemie9 studií
- Chronické onemocnění ledvin8 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.